8-K: InnovAge Soars: Q2 Profit Rebounds, FY26 Guidance Raised

InnovAge Holding Corp. announced strong fiscal second quarter 2026 financial results, reporting a significant return to profitability and raising its full fiscal year 2026 revenue and Adjusted EBITDA guidance.

Summary

• InnovAge reported total revenues of $239.7 million for the fiscal second quarter ended December 31, 2025, an increase of 14.7% compared to $209.0 million in the prior year.
• The company achieved net income of $11.8 million, or $0.08 per share, a substantial improvement from a net loss of $13.5 million, or $0.10 per share, in the second quarter of fiscal year 2025.
• Adjusted EBITDA for the quarter was $22.2 million, an increase of $16.3 million compared to $5.9 million in the same period last year, with an Adjusted EBITDA margin of 9.2%.
• Center-level Contribution Margin increased by 42.5% to $52.8 million, representing 22.0% of revenue.
• InnovAge's participant census grew to approximately 8,010, up from 7,480 participants in the second quarter of fiscal year 2025.
• The company ended the quarter with $83.2 million in cash and cash equivalents, $42.8 million in short-term investments, and $69.9 million in debt.
• InnovAge raised its full fiscal year 2026 financial guidance for total revenues to a range of $925 million to $950 million and Adjusted EBITDA to a range of $70 million to $75 million, while maintaining its census guidance of 7,900 to 8,100 participants.

Sentiment

Score: 8

Explanation: StockSavvy.ai views this as a highly positive report, reflecting a strong financial turnaround, significant operational improvements, and increased confidence from management as evidenced by the raised full-year guidance.

Positives

• Total revenues increased by 14.7% to $239.7 million.
• Shifted from a net loss of $13.5 million to a net income of $11.8 million.
• Net income margin improved significantly by 11.4 percentage points to 4.9%.
• Adjusted EBITDA surged by $16.3 million to $22.2 million, with the margin increasing by 6.4 percentage points to 9.2%.
• Center-level Contribution Margin grew by 42.5% to $52.8 million, with its percentage of revenue increasing by 4.3 percentage points to 22.0%.
• Participant census increased to 8,010, demonstrating continued growth in the number of seniors served.
• Full fiscal year 2026 guidance for total revenues and Adjusted EBITDA has been raised, indicating management's increased confidence in future performance.

Risks

• The viability of the growth strategy, including the ability to find suitable geographies for new centers, attract and retain participants, and obtain necessary licenses.
• Challenges in identifying, successfully completing, and integrating acquisitions, joint ventures, and other strategic partnerships.
• Impacts from ongoing macroeconomic challenges such as labor shortages, labor competition, inflation, tariffs, and trade disputes.
• Potential for inspections, reviews, audits, and investigations under federal and state government programs, and the ability to cure any identified deficiencies.
• Exposure to legal proceedings, enforcement actions, litigation, and disputes.
• The inherent risk under PACE contracts where the cost of providing services may exceed compensation.
• Dependence of revenues upon a limited number of government payors, including the risk of sudden loss of any government contracts.
• Impact of state and federal efforts to reduce healthcare spending, including recent legislation reducing Medicaid funding.
• Risk that submissions to government payors may contain inaccurate or unsupportable information, such as regarding risk adjustment scores, potentially leading to repayment obligations or penalties.
• The ability to comply with the continued listing requirements of Nasdaq.

Future Outlook

InnovAge is raising its full fiscal year 2026 financial guidance, with expected total revenues now between $925 million and $950 million, and Adjusted EBITDA projected to be between $70 million and $75 million. The guidance for ending participant census remains unchanged at 7,900 to 8,100, with total member months expected to be between 92,900 and 95,700.

Management Comments

• Patrick Blair, CEO, stated, "InnovAge delivered strong operating and financial results this quarter, reflecting continued progress in building a scalable, high-quality PACE platform."
• Blair added, "Our performance is rooted in disciplined execution and a care model that prioritizes clinical outcomes, participant experience, and responsible stewardship of public resources."
• Blair emphasized, "We remain focused on sustainable growth, close partnership with regulators, and long-term value for participants, payors, and shareholders."

Industry Context

StockSavvy.ai notes that InnovAge's strong performance and raised guidance underscore the growing demand for comprehensive healthcare programs for frail, dual-eligible seniors, particularly through the PACE model. The company's focus on clinical outcomes and responsible resource stewardship positions it well within a healthcare landscape increasingly prioritizing value-based care and cost efficiency for vulnerable populations. This positive trend suggests InnovAge is effectively capitalizing on the demographic shift towards an aging population and the associated need for integrated care solutions.

Comparison to Industry Standards

• The filing does not contain specific comparisons to industry standards or named competitors' projects and results.

Legal Proceedings

• The company mentions ongoing litigation by stockholders, civil investigative demands, and arbitration with a former pharmacy provider as part of its non-GAAP adjustments for litigation costs and settlement. Further details are referenced in Note 9, 'Commitments and Contingencies' of the condensed consolidated financial statements.

Stakeholder Impact

• Shareholders are positively impacted by the return to profitability, increased earnings per share, and raised financial guidance, suggesting potential for increased shareholder value.
• Participants benefit from the company's continued progress in building a scalable, high-quality PACE platform and a care model that prioritizes clinical outcomes and participant experience.
• Payors and government entities benefit from InnovAge's focus on responsible stewardship of public resources and efforts to reduce over-utilization of high-cost care settings.
• Employees may see positive impacts from the company's growth and business optimization initiatives, though organizational restructure costs were mentioned in the prior quarter.

Next Steps

• InnovAge will host a conference call on February 3, 2026, at 5:00 PM Eastern Time to discuss the financial results.
• The company will continue to focus on sustainable growth, close partnership with regulators, and long-term value creation for participants, payors, and shareholders.

Key Dates

Recommendation

The significant turnaround from a net loss to substantial net income, coupled with robust growth in key metrics like revenue, Adjusted EBITDA, and Center-level Contribution Margin, indicates strong operational execution. The raised full-year guidance further reinforces management's confidence and suggests continued positive momentum. This performance, especially in a critical healthcare segment, makes InnovAge an attractive investment for seasoned investors.

Keywords

InnovAge, INNV, PACE, Program of All-inclusive Care for the Elderly, Healthcare, Senior Care, Financial Results, Earnings, Adjusted EBITDA, Revenue, Guidance, Q2 2026, SEC Filing